(Q44414131)

2 December 2017

title

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma (English)

1 reference

preoperative chemotherapy

2 December 2017

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

27 December 2023

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

27 December 2023

author name string

Van Belle SJ

10

1 reference

2 December 2017

V. F. Cocquyt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

P. N. Blondeel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

H. T. Depypere

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

M. M. Praet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

V. R. Schelfhout

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

O. E. Silva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

J. Hurley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

R. F. Serreyn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

K. K. Daems

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

S. J P. Van Belle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711290

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711290

27 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0748798302914046?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

https://api.elsevier.com/content/article/PII:S0748798302914046?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

European Journal of Surgical Oncology

27 December 2023

published in

1 reference

2 December 2017

volume

29

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

361-367

1 reference

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

27 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

27 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

MRI of breast cancer: influence of chemotherapy on sensitivity

27 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

27 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

27 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

27 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery

27 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Canc

27 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

27 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy? A pathological assessment

27 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

27 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Prognostic factors in invasive lobular carcinoma of the breast: a multivariate analysis. A multicentre study after seventeen years of follow-up

27 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Conservative surgery and radiation therapy for invasive lobular carcinoma of the breast

27 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Role of conservation therapy for invasive lobular carcinoma of the breast

27 December 2023

22

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Optimal surgical treatment of invasive lobular carcinoma of the breast

27 December 2023

23

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma

27 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

27 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

One hundred free DIEP flap breast reconstructions: a personal experience.

27 December 2023

27

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

27 December 2023

28

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

27 December 2023

29

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

27 December 2023

30

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

27 December 2023

31

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

27 December 2023

The hunt for Ras targets

32

1 reference

https://api.crossref.org/works/10.1053/EJSO.2002.1404

27 December 2023

Identifiers

1 reference

2 December 2017

1 reference